IRIS
AVENALI, MICOL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 645
EU - Europa 411
AS - Asia 187
OC - Oceania 2
AF - Africa 1
Totale 1.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 641
IE - Irlanda 225
CN - Cina 163
IT - Italia 77
FI - Finlandia 38
DE - Germania 27
SG - Singapore 11
CZ - Repubblica Ceca 8
FR - Francia 7
NL - Olanda 7
BE - Belgio 5
GB - Regno Unito 5
IN - India 5
CA - Canada 4
JP - Giappone 4
RU - Federazione Russa 4
SE - Svezia 3
AU - Australia 2
AT - Austria 1
BD - Bangladesh 1
DK - Danimarca 1
ES - Italia 1
IR - Iran 1
LV - Lettonia 1
MY - Malesia 1
RO - Romania 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 1.246
Salva come PNG Salva come JPEG
Città #
Dublin 215
Chandler 204
Ashburn 45
Helsinki 35
Shanghai 35
Princeton 31
Lawrence 29
Medford 27
Boardman 26
Beijing 25
Nanjing 25
Wilmington 25
Milan 15
Hebei 14
Nanchang 13
New York 12
Fairfield 9
Seattle 9
Hangzhou 8
Amsterdam 7
Ann Arbor 7
Brno 7
Menlo Park 7
Chicago 6
Jacksonville 6
Norwalk 6
Rome 6
Shenyang 6
Brussels 5
Changsha 5
Falls Church 5
Los Angeles 5
Pune 5
Singapore 5
Cagliari 4
Messina 4
Tokyo 4
Toronto 4
Washington 4
Ningbo 3
Pavia 3
Piscataway 3
Pontoglio 3
Tianjin 3
Borås 2
Canberra 2
Como 2
Dearborn 2
Falkenstein 2
Frankfurt am Main 2
Houston 2
Jiaxing 2
Naples 2
Naro-Fominsk 2
Osio Sotto 2
Paris 2
Redwood City 2
Sittingbourne 2
Treviso 2
Austin 1
Basiglio 1
Berlin 1
Böblingen 1
Cambridge 1
Castelraimondo 1
Centurion 1
Cologne 1
Esslingen am Neckar 1
Fort Worth 1
Germantown 1
Gāzipur 1
Handan 1
Hefei 1
Las Vegas 1
London 1
Madrid 1
Magenta 1
Olomouc 1
Pingdingshan 1
Rho 1
Rognano 1
Saint Paul 1
Shijiazhuang 1
St Petersburg 1
Taiyuan 1
Turi 1
Vancouver 1
Vienna 1
Woodbridge 1
Zhuhai 1
Totale 986
Salva come PNG Salva come JPEG
Nome #
Consensus on the treatment of dysphagia in Parkinson's disease 58
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 57
Time for a consensus conference on pain in neurorehabilitation 54
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 53
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 52
CLINICAL AND BIOCHEMICAL SIGNATURES OF GBA-RELATED PARKINSON DISEASE 51
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 50
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 49
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 48
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism 46
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 44
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 42
KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset 42
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 41
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 40
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 37
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 36
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 34
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations 34
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: A 6-year longitudinal study 32
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 31
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 30
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 29
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 29
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 27
Outcomes of a computer-based cognitive training (CoRe) in early phases of cognitive decline: a data-driven cluster analysis 26
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 24
Reply to: “Increased alpha-Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations” 24
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 21
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 20
Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial 20
The remote assessment of parkinsonism supporting the ongoing development of interventions in Gaucher disease 19
A narrative review on the role and main findings of the Videofluoroscopic Study of Swallowing in Parkison's disease 17
Functional Study of SNCA p.V15A Variant: Further Linking α-Synuclein and Glucocerebrosidase 14
Proprioceptive Focal Stimulation (Equistasi®) May Improve the Quality of Gait in Middle-Moderate Parkinson's Disease Patients. Double-Blind, Double-Dummy, Randomized, Crossover, Italian Multicentric Study 13
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 12
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 10
Parkinson disease following COVID-19: Report of six cases 10
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 6
Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects 4
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 3
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study 3
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort 3
Pain in focal dystonias - A focused review to address an important component of the disease 2
Totale 1.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.473
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 32 46 0 2 1 0 0 2 10 7 10 0
2020/202148 0 1 16 2 3 4 0 11 6 3 1 1
2021/2022172 0 1 0 16 9 12 3 13 9 1 19 89
2022/2023549 54 54 5 67 31 40 1 22 251 3 15 6
2023/2024356 37 47 8 22 9 69 29 24 2 11 50 48
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 1.297